Literature DB >> 29649395

Top Ten Tips Palliative Care Clinicians Should Know When Caring for Patients with Endometrial Cancer.

Brittany A Davidson1, Haley A Moss1, Jaclyn Arquiette2, Arif H Kamal3.   

Abstract

Endometrial cancer incidence has been increasing over the last two decades, likely due to the obesity epidemic. The majority of these cancers are confined to the uterus at diagnosis and can be cured with surgery. Overall, five-year disease-specific survival is about 80%, but some patients have locally advanced or metastatic disease that is not amenable to control with radiation and/or chemotherapy. Disease-related symptoms are most common in this subset of patients with endometrial cancer, although women with early-stage disease may also experience side effects related to surgical menopause or adjuvant treatment. In recent years, professional societies have been increasingly vocal about the importance of incorporating palliative care early in a patient's disease course. As these calls increase, palliative care clinicians will likely increasingly comanage patients with advanced or recurrent endometrial cancer. We brought together a team of gynecologic oncology and palliative care experts to assemble practical tips for the care of women with endometrial cancer. In this article, we use a "Top 10" format to highlight issues that may help palliative care physicians understand a patient's prognosis, address common misconceptions about endometrial cancer, and improve the quality of shared decision making and goals of care discussions.

Entities:  

Keywords:  endometrial cancer; gynecologic oncology; palliative care; symptom management

Mesh:

Year:  2018        PMID: 29649395     DOI: 10.1089/jpm.2018.0053

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  3 in total

1.  Analysis of Prognostic Factors and Treatment Modes of Patients with Recurrent Endometrial Carcinoma.

Authors:  Yi Li; Dong Yang; Shuangjian Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-18       Impact factor: 2.629

2.  Immune Cell Infiltration as Signatures for the Diagnosis and Prognosis of Malignant Gynecological Tumors.

Authors:  Qi-Fang Liu; Zi-Yi Feng; Li-Li Jiang; Tong-Tong Xu; Si-Man Li; Kui-Ran Liu
Journal:  Front Cell Dev Biol       Date:  2021-06-17

3.  Clinicopathological Characteristics and Prognosis in Endometrial Cancer With Bone Metastasis: A SEER-Based Study of 584 Women.

Authors:  Hejia Hu; Zhan Wang; Miaofeng Zhang; Feng Niu; Qunfei Yu; Ying Ren; Zhaoming Ye
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.